Uveitis	B:C0042164
in	O
spondyloarthritis	O
patients	O
and	O
its	O
association	O
with	O
HLA	O
-	I:C0019740
B27	I:C0019740
histocompatibility	I:C0019740
antigen	I:C0019740
:	O
prospective	O
study	I:C0033522
.	O

Uveitis	O
in	O
spondyloarthritis	B:C0949690
patients	O
and	O
its	O
association	O
with	O
HLA	O
-	I:C0019740
B27	I:C0019740
histocompatibility	I:C0019740
antigen	I:C0019740
:	O
prospective	O
study	I:C0033522
.	O

Uveitis	O
in	O
spondyloarthritis	O
patients	O
and	O
its	O
association	O
with	O
HLA	B:C0019740
-	I:C0019740
B27	I:C0019740
histocompatibility	I:C0019740
antigen	I:C0019740
:	O
prospective	O
study	I:C0033522
.	O

Uveitis	O
in	O
spondyloarthritis	O
patients	O
and	O
its	O
association	O
with	O
HLA	O
-	I:C0019740
B27	I:C0019740
histocompatibility	I:C0019740
antigen	I:C0019740
:	O
prospective	B:C0033522
study	I:C0033522
.	O

T	O
o	O
perform	O
a	O
prospective	B:C0033522
study	I:C0033522
of	O
clinical	O
presentation	O
and	O
course	O
of	O
uveitis	O
in	O
spondyloarthritis	O
(	O
spondyloarthritis	O
)	O
patients	O
as	O
well	O
as	O
its	O
association	O
with	O
the	O
HLA	O
-	I:C0019740
B27	I:C0019740
histocompatibility	I:C0019740
antigen	I:C0019740
.	O

T	O
o	O
perform	O
a	O
prospective	O
study	I:C0033522
of	O
clinical	O
presentation	O
and	O
course	O
of	O
uveitis	B:C0042164
in	O
spondyloarthritis	O
(	O
spondyloarthritis	O
)	O
patients	O
as	O
well	O
as	O
its	O
association	O
with	O
the	O
HLA	O
-	I:C0019740
B27	I:C0019740
histocompatibility	I:C0019740
antigen	I:C0019740
.	O

T	O
o	O
perform	O
a	O
prospective	O
study	I:C0033522
of	O
clinical	O
presentation	O
and	O
course	O
of	O
uveitis	O
in	O
spondyloarthritis	B:C0949690
(	O
spondyloarthritis	O
)	O
patients	O
as	O
well	O
as	O
its	O
association	O
with	O
the	O
HLA	O
-	I:C0019740
B27	I:C0019740
histocompatibility	I:C0019740
antigen	I:C0019740
.	O

T	O
o	O
perform	O
a	O
prospective	O
study	I:C0033522
of	O
clinical	O
presentation	O
and	O
course	O
of	O
uveitis	O
in	O
spondyloarthritis	O
(	O
spondyloarthritis	B:C0949690
)	O
patients	O
as	O
well	O
as	O
its	O
association	O
with	O
the	O
HLA	O
-	I:C0019740
B27	I:C0019740
histocompatibility	I:C0019740
antigen	I:C0019740
.	O

T	O
o	O
perform	O
a	O
prospective	O
study	I:C0033522
of	O
clinical	O
presentation	O
and	O
course	O
of	O
uveitis	O
in	O
spondyloarthritis	O
(	O
spondyloarthritis	O
)	O
patients	O
as	O
well	O
as	O
its	O
association	O
with	O
the	O
HLA	B:C0019740
-	I:C0019740
B27	I:C0019740
histocompatibility	I:C0019740
antigen	I:C0019740
.	O

The	O
study	B:C2603343
included	O
219	O
patients	O
with	O
uveitis	O
,	O
all	O
tested	O
for	O
HLA	O
-	I:C0019740
B27	I:C0019740
antigen	I:C0019740
and	O
various	O
infections	O
(	O
viral	O
,	O
bacterial	O
,	O
and	O
parasitic	O
)	O
as	O
well	O
as	O
examined	O
for	O
locomotive	O
system	I:C0026860
involvement	O
.	O

The	O
study	O
included	O
219	O
patients	O
with	O
uveitis	B:C0042164
,	O
all	O
tested	O
for	O
HLA	O
-	I:C0019740
B27	I:C0019740
antigen	I:C0019740
and	O
various	O
infections	O
(	O
viral	O
,	O
bacterial	O
,	O
and	O
parasitic	O
)	O
as	O
well	O
as	O
examined	O
for	O
locomotive	O
system	I:C0026860
involvement	O
.	O

The	O
study	O
included	O
219	O
patients	O
with	O
uveitis	O
,	O
all	O
tested	O
for	O
HLA	B:C0019740
-	I:C0019740
B27	I:C0019740
antigen	I:C0019740
and	O
various	O
infections	O
(	O
viral	O
,	O
bacterial	O
,	O
and	O
parasitic	O
)	O
as	O
well	O
as	O
examined	O
for	O
locomotive	O
system	I:C0026860
involvement	O
.	O

The	O
study	O
included	O
219	O
patients	O
with	O
uveitis	O
,	O
all	O
tested	O
for	O
HLA	O
-	I:C0019740
B27	I:C0019740
antigen	I:C0019740
and	O
various	O
infections	B:C3714514
(	O
viral	O
,	O
bacterial	O
,	O
and	O
parasitic	O
)	O
as	O
well	O
as	O
examined	O
for	O
locomotive	O
system	I:C0026860
involvement	O
.	O

The	O
study	O
included	O
219	O
patients	O
with	O
uveitis	O
,	O
all	O
tested	O
for	O
HLA	O
-	I:C0019740
B27	I:C0019740
antigen	I:C0019740
and	O
various	O
infections	O
(	O
viral	B:C0042769
,	O
bacterial	O
,	O
and	O
parasitic	O
)	O
as	O
well	O
as	O
examined	O
for	O
locomotive	O
system	I:C0026860
involvement	O
.	O

The	O
study	O
included	O
219	O
patients	O
with	O
uveitis	O
,	O
all	O
tested	O
for	O
HLA	O
-	I:C0019740
B27	I:C0019740
antigen	I:C0019740
and	O
various	O
infections	O
(	O
viral	O
,	O
bacterial	B:C0004623
,	O
and	O
parasitic	O
)	O
as	O
well	O
as	O
examined	O
for	O
locomotive	O
system	I:C0026860
involvement	O
.	O

The	O
study	O
included	O
219	O
patients	O
with	O
uveitis	O
,	O
all	O
tested	O
for	O
HLA	O
-	I:C0019740
B27	I:C0019740
antigen	I:C0019740
and	O
various	O
infections	O
(	O
viral	O
,	O
bacterial	O
,	O
and	O
parasitic	B:C0747256
)	O
as	O
well	O
as	O
examined	O
for	O
locomotive	O
system	I:C0026860
involvement	O
.	O

The	O
study	O
included	O
219	O
patients	O
with	O
uveitis	O
,	O
all	O
tested	O
for	O
HLA	O
-	I:C0019740
B27	I:C0019740
antigen	I:C0019740
and	O
various	O
infections	O
(	O
viral	O
,	O
bacterial	O
,	O
and	O
parasitic	O
)	O
as	O
well	O
as	O
examined	B:C0332128
for	O
locomotive	O
system	I:C0026860
involvement	O
.	O

The	O
study	O
included	O
219	O
patients	O
with	O
uveitis	O
,	O
all	O
tested	O
for	O
HLA	O
-	I:C0019740
B27	I:C0019740
antigen	I:C0019740
and	O
various	O
infections	O
(	O
viral	O
,	O
bacterial	O
,	O
and	O
parasitic	O
)	O
as	O
well	O
as	O
examined	O
for	O
locomotive	B:C0026860
system	I:C0026860
involvement	O
.	O

The	O
presence	B:C0150312
of	O
the	O
HLA	O
-	I:C0019740
B27	I:C0019740
antigen	I:C0019740
was	O
determined	O
in	O
142	O
(	O
64.8	O
%	O
)	O
out	O
of	O
219	O
patients	O
,	O
of	O
them	O
87	O
were	O
diagnosed	O
with	O
an	O
entity	O
of	O
the	O
spondyloarthritis	O
group	O
.	O

The	O
presence	O
of	O
the	O
HLA	B:C0019740
-	I:C0019740
B27	I:C0019740
antigen	I:C0019740
was	O
determined	O
in	O
142	O
(	O
64.8	O
%	O
)	O
out	O
of	O
219	O
patients	O
,	O
of	O
them	O
87	O
were	O
diagnosed	O
with	O
an	O
entity	O
of	O
the	O
spondyloarthritis	O
group	O
.	O

The	O
presence	O
of	O
the	O
HLA	O
-	I:C0019740
B27	I:C0019740
antigen	I:C0019740
was	O
determined	O
in	O
142	O
(	O
64.8	O
%	O
)	O
out	O
of	O
219	O
patients	O
,	O
of	O
them	O
87	O
were	O
diagnosed	B:C0011900
with	O
an	O
entity	O
of	O
the	O
spondyloarthritis	O
group	O
.	O

The	O
presence	O
of	O
the	O
HLA	O
-	I:C0019740
B27	I:C0019740
antigen	I:C0019740
was	O
determined	O
in	O
142	O
(	O
64.8	O
%	O
)	O
out	O
of	O
219	O
patients	O
,	O
of	O
them	O
87	O
were	O
diagnosed	O
with	O
an	O
entity	O
of	O
the	O
spondyloarthritis	B:C0949690
group	O
.	O

The	O
remaining	O
77	O
(	O
35.2	O
%	O
)	O
patients	O
appeared	O
to	O
be	O
HLA	B:C0019740
-	I:C0019740
B27	I:C0019740
-	O
negative	O
,	O
but	O
13	O
were	O
still	O
diagnosed	O
with	O
an	O
entity	O
of	O
the	O
spondyloarthritis	O
group	O
.	O

The	O
remaining	O
77	O
(	O
35.2	O
%	O
)	O
patients	O
appeared	O
to	O
be	O
HLA	O
-	I:C0019740
B27	I:C0019740
-	O
negative	B:C0205160
,	O
but	O
13	O
were	O
still	O
diagnosed	O
with	O
an	O
entity	O
of	O
the	O
spondyloarthritis	O
group	O
.	O

The	O
remaining	O
77	O
(	O
35.2	O
%	O
)	O
patients	O
appeared	O
to	O
be	O
HLA	O
-	I:C0019740
B27	I:C0019740
-	O
negative	O
,	O
but	O
13	O
were	O
still	O
diagnosed	B:C0011900
with	O
an	O
entity	O
of	O
the	O
spondyloarthritis	O
group	O
.	O

The	O
remaining	O
77	O
(	O
35.2	O
%	O
)	O
patients	O
appeared	O
to	O
be	O
HLA	O
-	I:C0019740
B27	I:C0019740
-	O
negative	O
,	O
but	O
13	O
were	O
still	O
diagnosed	O
with	O
an	O
entity	O
of	O
the	O
spondyloarthritis	B:C0949690
group	O
.	O

There	O
were	O
10	O
(	O
4.6	O
%	O
)	O
patients	O
with	O
2	O
or	O
more	O
diseases	B:C0012634
from	O
the	O
spondyloarthritis	O
group	O
(	O
«	O
clinical	O
decussation	O
»	O
)	O
.	O

There	O
were	O
10	O
(	O
4.6	O
%	O
)	O
patients	O
with	O
2	O
or	O
more	O
diseases	O
from	O
the	O
spondyloarthritis	B:C0949690
group	O
(	O
«	O
clinical	O
decussation	O
»	O
)	O
.	O

When	O
comparing	O
the	O
two	O
groups	O
of	O
HLA	O
-	O
B27	O
-	O
positive	O
and	O
negative	B:C0205160
patients	O
having	O
both	O
spondyloarthritis	O
and	O
uveitis	O
,	O
no	O
statistically	O
significant	O
difference	O
was	O
found	O
as	O
to	O
the	O
age	O
of	O
onset	O
,	O
site	O
,	O
frequency	O
of	O
attacks	O
,	O
and	O
uni	O
-	O
or	O
bilateral	O
involvement	O
(	O
p>0.05	O
)	O
.	O

When	O
comparing	O
the	O
two	O
groups	O
of	O
HLA	O
-	O
B27	O
-	O
positive	O
and	O
negative	O
patients	O
having	O
both	O
spondyloarthritis	B:C0949690
and	O
uveitis	O
,	O
no	O
statistically	O
significant	O
difference	O
was	O
found	O
as	O
to	O
the	O
age	O
of	O
onset	O
,	O
site	O
,	O
frequency	O
of	O
attacks	O
,	O
and	O
uni	O
-	O
or	O
bilateral	O
involvement	O
(	O
p>0.05	O
)	O
.	O

When	O
comparing	O
the	O
two	O
groups	O
of	O
HLA	O
-	O
B27	O
-	O
positive	O
and	O
negative	O
patients	O
having	O
both	O
spondyloarthritis	O
and	O
uveitis	B:C0042164
,	O
no	O
statistically	O
significant	O
difference	O
was	O
found	O
as	O
to	O
the	O
age	O
of	O
onset	O
,	O
site	O
,	O
frequency	O
of	O
attacks	O
,	O
and	O
uni	O
-	O
or	O
bilateral	O
involvement	O
(	O
p>0.05	O
)	O
.	O

When	O
comparing	O
the	O
two	O
groups	O
of	O
HLA	O
-	O
B27	O
-	O
positive	O
and	O
negative	O
patients	O
having	O
both	O
spondyloarthritis	O
and	O
uveitis	O
,	O
no	O
statistically	O
significant	O
difference	O
was	O
found	O
as	O
to	O
the	O
age	O
of	O
onset	O
,	O
site	B:C1515974
,	O
frequency	O
of	O
attacks	O
,	O
and	O
uni	O
-	O
or	O
bilateral	O
involvement	O
(	O
p>0.05	O
)	O
.	O

When	O
comparing	O
the	O
two	O
groups	O
of	O
HLA	O
-	O
B27	O
-	O
positive	O
and	O
negative	O
patients	O
having	O
both	O
spondyloarthritis	O
and	O
uveitis	O
,	O
no	O
statistically	O
significant	O
difference	O
was	O
found	O
as	O
to	O
the	O
age	O
of	O
onset	O
,	O
site	O
,	O
frequency	O
of	O
attacks	O
,	O
and	O
uni	B:C0205092
-	O
or	O
bilateral	O
involvement	O
(	O
p>0.05	O
)	O
.	O

When	O
comparing	O
the	O
two	O
groups	O
of	O
HLA	O
-	O
B27	O
-	O
positive	O
and	O
negative	O
patients	O
having	O
both	O
spondyloarthritis	O
and	O
uveitis	O
,	O
no	O
statistically	O
significant	O
difference	O
was	O
found	O
as	O
to	O
the	O
age	O
of	O
onset	O
,	O
site	O
,	O
frequency	O
of	O
attacks	O
,	O
and	O
uni	O
-	O
or	O
bilateral	B:C0238767
involvement	O
(	O
p>0.05	O
)	O
.	O

We	O
also	O
performed	O
a	O
comparison	O
of	O
HLA	O
-	O
B27	O
-	O
positive	O
and	O
negative	B:C0205160
patients	O
with	O
no	O
account	O
to	O
their	O
spondyloarthritis	O
status	O
and	O
revealed	O
a	O
higher	O
complication	O
rate	O
in	O
those	O
that	O
were	O
«	O
negative	O
»	O
(	O
p<0.0001	O
)	O
,	O
which	O
can	O
be	O
explained	O
by	O
the	O
fact	O
that	O
HLA	O
-	I:C0019740
B27	I:C0019740
-	O
negative	O
patients	O
often	O
have	O
autoimmune	O
or	O
infectious	O
uveitis	I:C0042164
of	O
different	O
origin	O
notable	O
for	O
long	O
attacks	O
and	O
short	O
remissions	O
.	O

We	O
also	O
performed	O
a	O
comparison	O
of	O
HLA	O
-	O
B27	O
-	O
positive	O
and	O
negative	O
patients	O
with	O
no	O
account	O
to	O
their	O
spondyloarthritis	B:C0949690
status	O
and	O
revealed	O
a	O
higher	O
complication	O
rate	O
in	O
those	O
that	O
were	O
«	O
negative	O
»	O
(	O
p<0.0001	O
)	O
,	O
which	O
can	O
be	O
explained	O
by	O
the	O
fact	O
that	O
HLA	O
-	I:C0019740
B27	I:C0019740
-	O
negative	O
patients	O
often	O
have	O
autoimmune	O
or	O
infectious	O
uveitis	I:C0042164
of	O
different	O
origin	O
notable	O
for	O
long	O
attacks	O
and	O
short	O
remissions	O
.	O

We	O
also	O
performed	O
a	O
comparison	O
of	O
HLA	O
-	O
B27	O
-	O
positive	O
and	O
negative	O
patients	O
with	O
no	O
account	O
to	O
their	O
spondyloarthritis	O
status	O
and	O
revealed	O
a	O
higher	O
complication	B:C0009566
rate	O
in	O
those	O
that	O
were	O
«	O
negative	O
»	O
(	O
p<0.0001	O
)	O
,	O
which	O
can	O
be	O
explained	O
by	O
the	O
fact	O
that	O
HLA	O
-	I:C0019740
B27	I:C0019740
-	O
negative	O
patients	O
often	O
have	O
autoimmune	O
or	O
infectious	O
uveitis	I:C0042164
of	O
different	O
origin	O
notable	O
for	O
long	O
attacks	O
and	O
short	O
remissions	O
.	O

We	O
also	O
performed	O
a	O
comparison	O
of	O
HLA	O
-	O
B27	O
-	O
positive	O
and	O
negative	O
patients	O
with	O
no	O
account	O
to	O
their	O
spondyloarthritis	O
status	O
and	O
revealed	O
a	O
higher	O
complication	O
rate	O
in	O
those	O
that	O
were	O
«	O
negative	B:C0205160
»	O
(	O
p<0.0001	O
)	O
,	O
which	O
can	O
be	O
explained	O
by	O
the	O
fact	O
that	O
HLA	O
-	I:C0019740
B27	I:C0019740
-	O
negative	O
patients	O
often	O
have	O
autoimmune	O
or	O
infectious	O
uveitis	I:C0042164
of	O
different	O
origin	O
notable	O
for	O
long	O
attacks	O
and	O
short	O
remissions	O
.	O

We	O
also	O
performed	O
a	O
comparison	O
of	O
HLA	O
-	O
B27	O
-	O
positive	O
and	O
negative	O
patients	O
with	O
no	O
account	O
to	O
their	O
spondyloarthritis	O
status	O
and	O
revealed	O
a	O
higher	O
complication	O
rate	O
in	O
those	O
that	O
were	O
«	O
negative	O
»	O
(	O
p<0.0001	O
)	O
,	O
which	O
can	O
be	O
explained	O
by	O
the	O
fact	O
that	O
HLA	B:C0019740
-	I:C0019740
B27	I:C0019740
-	O
negative	O
patients	O
often	O
have	O
autoimmune	O
or	O
infectious	O
uveitis	I:C0042164
of	O
different	O
origin	O
notable	O
for	O
long	O
attacks	O
and	O
short	O
remissions	O
.	O

We	O
also	O
performed	O
a	O
comparison	O
of	O
HLA	O
-	O
B27	O
-	O
positive	O
and	O
negative	O
patients	O
with	O
no	O
account	O
to	O
their	O
spondyloarthritis	O
status	O
and	O
revealed	O
a	O
higher	O
complication	O
rate	O
in	O
those	O
that	O
were	O
«	O
negative	O
»	O
(	O
p<0.0001	O
)	O
,	O
which	O
can	O
be	O
explained	O
by	O
the	O
fact	O
that	O
HLA	O
-	I:C0019740
B27	I:C0019740
-	O
negative	B:C0205160
patients	O
often	O
have	O
autoimmune	O
or	O
infectious	O
uveitis	I:C0042164
of	O
different	O
origin	O
notable	O
for	O
long	O
attacks	O
and	O
short	O
remissions	O
.	O

We	O
also	O
performed	O
a	O
comparison	O
of	O
HLA	O
-	O
B27	O
-	O
positive	O
and	O
negative	O
patients	O
with	O
no	O
account	O
to	O
their	O
spondyloarthritis	O
status	O
and	O
revealed	O
a	O
higher	O
complication	O
rate	O
in	O
those	O
that	O
were	O
«	O
negative	O
»	O
(	O
p<0.0001	O
)	O
,	O
which	O
can	O
be	O
explained	O
by	O
the	O
fact	O
that	O
HLA	O
-	I:C0019740
B27	I:C0019740
-	O
negative	O
patients	O
often	O
have	O
autoimmune	B:C3888523
or	O
infectious	O
uveitis	I:C0042164
of	O
different	O
origin	O
notable	O
for	O
long	O
attacks	O
and	O
short	O
remissions	O
.	O

We	O
also	O
performed	O
a	O
comparison	O
of	O
HLA	O
-	O
B27	O
-	O
positive	O
and	O
negative	O
patients	O
with	O
no	O
account	O
to	O
their	O
spondyloarthritis	O
status	O
and	O
revealed	O
a	O
higher	O
complication	O
rate	O
in	O
those	O
that	O
were	O
«	O
negative	O
»	O
(	O
p<0.0001	O
)	O
,	O
which	O
can	O
be	O
explained	O
by	O
the	O
fact	O
that	O
HLA	O
-	I:C0019740
B27	I:C0019740
-	O
negative	O
patients	O
often	O
have	O
autoimmune	O
or	O
infectious	B:C0042164
uveitis	I:C0042164
of	O
different	O
origin	O
notable	O
for	O
long	O
attacks	O
and	O
short	O
remissions	O
.	O

We	O
also	O
performed	O
a	O
comparison	O
of	O
HLA	O
-	O
B27	O
-	O
positive	O
and	O
negative	O
patients	O
with	O
no	O
account	O
to	O
their	O
spondyloarthritis	O
status	O
and	O
revealed	O
a	O
higher	O
complication	O
rate	O
in	O
those	O
that	O
were	O
«	O
negative	O
»	O
(	O
p<0.0001	O
)	O
,	O
which	O
can	O
be	O
explained	O
by	O
the	O
fact	O
that	O
HLA	O
-	I:C0019740
B27	I:C0019740
-	O
negative	O
patients	O
often	O
have	O
autoimmune	O
or	O
infectious	O
uveitis	I:C0042164
of	O
different	O
origin	O
notable	O
for	O
long	O
attacks	O
and	O
short	O
remissions	B:C0544452
.	O

Assessing	O
the	O
site	B:C1515974
and	O
course	O
of	O
uveitis	O
as	O
well	O
as	O
HLA	O
-	I:C0019740
B27	I:C0019740
testing	O
of	O
uveitis	O
patients	O
has	O
proved	O
important	O
for	O
etiological	O
diagnosis	O
.	O

Assessing	O
the	O
site	O
and	O
course	O
of	O
uveitis	B:C0042164
as	O
well	O
as	O
HLA	O
-	I:C0019740
B27	I:C0019740
testing	O
of	O
uveitis	O
patients	O
has	O
proved	O
important	O
for	O
etiological	O
diagnosis	O
.	O

Assessing	O
the	O
site	O
and	O
course	O
of	O
uveitis	O
as	O
well	O
as	O
HLA	B:C0019740
-	I:C0019740
B27	I:C0019740
testing	O
of	O
uveitis	O
patients	O
has	O
proved	O
important	O
for	O
etiological	O
diagnosis	O
.	O

Assessing	O
the	O
site	O
and	O
course	O
of	O
uveitis	O
as	O
well	O
as	O
HLA	O
-	I:C0019740
B27	I:C0019740
testing	O
of	O
uveitis	B:C0042164
patients	O
has	O
proved	O
important	O
for	O
etiological	O
diagnosis	O
.	O

Assessing	O
the	O
site	O
and	O
course	O
of	O
uveitis	O
as	O
well	O
as	O
HLA	O
-	I:C0019740
B27	I:C0019740
testing	O
of	O
uveitis	O
patients	O
has	O
proved	O
important	O
for	O
etiological	O
diagnosis	B:C0011900
.	O

Diseases	B:C0012634
of	O
the	O
spondyloarthritis	O
group	O
have	O
been	O
shown	O
to	O
be	O
6.7	O
times	O
more	O
common	O
in	O
HLA	O
-	O
B27	O
-	O
positive	O
patients	O
as	O
compared	O
to	O
HLA	O
-	I:C0019740
B27	I:C0019740
-	O
negative	O
ones	O
.	O

Diseases	O
of	O
the	O
spondyloarthritis	B:C0949690
group	O
have	O
been	O
shown	O
to	O
be	O
6.7	O
times	O
more	O
common	O
in	O
HLA	O
-	O
B27	O
-	O
positive	O
patients	O
as	O
compared	O
to	O
HLA	O
-	I:C0019740
B27	I:C0019740
-	O
negative	O
ones	O
.	O

Diseases	O
of	O
the	O
spondyloarthritis	O
group	O
have	O
been	O
shown	O
to	O
be	O
6.7	O
times	O
more	O
common	O
in	O
HLA	O
-	O
B27	O
-	O
positive	O
patients	O
as	O
compared	O
to	O
HLA	B:C0019740
-	I:C0019740
B27	I:C0019740
-	O
negative	O
ones	O
.	O

Diseases	O
of	O
the	O
spondyloarthritis	O
group	O
have	O
been	O
shown	O
to	O
be	O
6.7	O
times	O
more	O
common	O
in	O
HLA	O
-	O
B27	O
-	O
positive	O
patients	O
as	O
compared	O
to	O
HLA	O
-	I:C0019740
B27	I:C0019740
-	O
negative	B:C0205160
ones	O
.	O

Clinical	O
presentation	O
of	O
uveitis	B:C0042164
in	O
the	O
presence	O
of	O
spondyloarthritis	O
in	O
both	O
HLA	O
-	O
B27	O
-	O
positive	O
and	O
negative	O
patients	O
resembles	O
that	O
of	O
idiopathic	O
uveitis	I:C0042164
-	O
an	O
independent	O
HLA	O
-	I:C0019740
B27	I:C0019740
-	O
associated	O
syndrome	O
(	O
р>0.05	O
)	O
.	O

Clinical	O
presentation	O
of	O
uveitis	O
in	O
the	O
presence	B:C0150312
of	O
spondyloarthritis	O
in	O
both	O
HLA	O
-	O
B27	O
-	O
positive	O
and	O
negative	O
patients	O
resembles	O
that	O
of	O
idiopathic	O
uveitis	I:C0042164
-	O
an	O
independent	O
HLA	O
-	I:C0019740
B27	I:C0019740
-	O
associated	O
syndrome	O
(	O
р>0.05	O
)	O
.	O

Clinical	O
presentation	O
of	O
uveitis	O
in	O
the	O
presence	O
of	O
spondyloarthritis	B:C0949690
in	O
both	O
HLA	O
-	O
B27	O
-	O
positive	O
and	O
negative	O
patients	O
resembles	O
that	O
of	O
idiopathic	O
uveitis	I:C0042164
-	O
an	O
independent	O
HLA	O
-	I:C0019740
B27	I:C0019740
-	O
associated	O
syndrome	O
(	O
р>0.05	O
)	O
.	O

Clinical	O
presentation	O
of	O
uveitis	O
in	O
the	O
presence	O
of	O
spondyloarthritis	O
in	O
both	O
HLA	O
-	O
B27	O
-	O
positive	O
and	O
negative	B:C0205160
patients	O
resembles	O
that	O
of	O
idiopathic	O
uveitis	I:C0042164
-	O
an	O
independent	O
HLA	O
-	I:C0019740
B27	I:C0019740
-	O
associated	O
syndrome	O
(	O
р>0.05	O
)	O
.	O

Clinical	O
presentation	O
of	O
uveitis	O
in	O
the	O
presence	O
of	O
spondyloarthritis	O
in	O
both	O
HLA	O
-	O
B27	O
-	O
positive	O
and	O
negative	O
patients	O
resembles	O
that	O
of	O
idiopathic	B:C0042164
uveitis	I:C0042164
-	O
an	O
independent	O
HLA	O
-	I:C0019740
B27	I:C0019740
-	O
associated	O
syndrome	O
(	O
р>0.05	O
)	O
.	O

Clinical	O
presentation	O
of	O
uveitis	O
in	O
the	O
presence	O
of	O
spondyloarthritis	O
in	O
both	O
HLA	O
-	O
B27	O
-	O
positive	O
and	O
negative	O
patients	O
resembles	O
that	O
of	O
idiopathic	O
uveitis	I:C0042164
-	O
an	O
independent	O
HLA	B:C0019740
-	I:C0019740
B27	I:C0019740
-	O
associated	O
syndrome	O
(	O
р>0.05	O
)	O
.	O

Clinical	O
presentation	O
of	O
uveitis	O
in	O
the	O
presence	O
of	O
spondyloarthritis	O
in	O
both	O
HLA	O
-	O
B27	O
-	O
positive	O
and	O
negative	O
patients	O
resembles	O
that	O
of	O
idiopathic	O
uveitis	I:C0042164
-	O
an	O
independent	O
HLA	O
-	I:C0019740
B27	I:C0019740
-	O
associated	O
syndrome	B:C0039082
(	O
р>0.05	O
)	O
.	O

Cases	O
of	O
«	O
decussation	O
»	O
between	O
entities	O
of	O
the	O
spondyloarthritis	B:C0949690
group	O
are	O
usually	O
more	O
severe	O
in	O
terms	O
of	O
clinical	O
presentation	O
and	O
course	O
of	O
uveitis	O
and	O
are	O
associated	O
with	O
a	O
worse	O
prognosis	I:C0278252
.	O

Cases	O
of	O
«	O
decussation	O
»	O
between	O
entities	O
of	O
the	O
spondyloarthritis	O
group	O
are	O
usually	O
more	O
severe	O
in	O
terms	O
of	O
clinical	O
presentation	O
and	O
course	O
of	O
uveitis	B:C0042164
and	O
are	O
associated	O
with	O
a	O
worse	O
prognosis	I:C0278252
.	O

Cases	O
of	O
«	O
decussation	O
»	O
between	O
entities	O
of	O
the	O
spondyloarthritis	O
group	O
are	O
usually	O
more	O
severe	O
in	O
terms	O
of	O
clinical	O
presentation	O
and	O
course	O
of	O
uveitis	O
and	O
are	O
associated	O
with	O
a	O
worse	B:C0278252
prognosis	I:C0278252
.	O

Complications	B:C0009566
of	O
uveitis	O
are	O
more	O
likely	O
to	O
be	O
found	O
in	O
non-SpA	O
HLA	O
-	I:C0019740
B27	I:C0019740
-	O
negative	O
patients	O
(	O
р	O
<	O
0.0001	O
)	O
.	O

Complications	O
of	O
uveitis	B:C0042164
are	O
more	O
likely	O
to	O
be	O
found	O
in	O
non-SpA	O
HLA	O
-	I:C0019740
B27	I:C0019740
-	O
negative	O
patients	O
(	O
р	O
<	O
0.0001	O
)	O
.	O

Complications	O
of	O
uveitis	O
are	O
more	O
likely	O
to	O
be	O
found	O
in	O
non-SpA	B:C0243095
HLA	O
-	I:C0019740
B27	I:C0019740
-	O
negative	O
patients	O
(	O
р	O
<	O
0.0001	O
)	O
.	O

Complications	O
of	O
uveitis	O
are	O
more	O
likely	O
to	O
be	O
found	O
in	O
non-SpA	O
HLA	B:C0019740
-	I:C0019740
B27	I:C0019740
-	O
negative	O
patients	O
(	O
р	O
<	O
0.0001	O
)	O
.	O

Complications	O
of	O
uveitis	O
are	O
more	O
likely	O
to	O
be	O
found	O
in	O
non-SpA	O
HLA	O
-	I:C0019740
B27	I:C0019740
-	O
negative	B:C0205160
patients	O
(	O
р	O
<	O
0.0001	O
)	O
.	O

